Labviva
Cambridge, US · Founded 2017 · Delaware corporation · 68 employees on LinkedIn · 8 known investors
Labviva is an AI-native procurement platform that unifies the life sciences supply chain, helping research organizations optimize procurement processes and reduce costs. The platform serves life sciences companies and research institutions by automating lab operations and inventory management.
Founders & leadership
Labviva was founded in 2017 by Siamak and Siamak Baharloo.
S
SB
Siamak BaharlooinCEO & Co-FounderExecutive Officer and Director of Labviva, a digital marketplace connecting life science researchers with suppliers of reagents, chemicals, and instrumentation.
C
CarloinGM of Europe
NP
Nick PremnathinSVP of Commercial Strategy
AM
Aaron MiramontesNamed on SEC filing
NR
Nicholas RiouxinCTO & Co-Founder
R
RenikainFounder
J
JenniferinFounder
Board
Investors · 8
BIOSPRING PARTNERS✓ verifiedNew York
Glasswing Ventures✓ verifiedBoston · $100K – $5M
Village Global✓ verifiedCovina · $100K – $500K
.jpeg){kind=logo}
B Capital GroupManhattan Beach · $10M – $50M
B4 Capital$10M – $50M
MassVenturesWaltham · $250K – $500K
53 StationsreportedBoston
Also in the syndicate · 1
B Capital Group Management LP
Funding
SEC filings, press & company announcements$33.8M disclosed across 3 rounds · 2019–2025
- $25MSeries BJan 2025 · 2 sources
53 Stations (lead), B Capital Group Management LP, Biospring Partners LP, Glasswing Ventures
Source ↗ - $20MSeries AMar 2023 · 2 sourcesSource ↗
▶$8MraisedJun 2021 · 3 investors · Other TechnologyRule 506(b)
▶$8MraisedJun 2021 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas RiouxExecutive Officer, Director
- Evan LodesDirector
- Siamak BaharlooExecutive Officer, Director
- Aaron MiramontesExecutive Officer
- Sarah FayDirector
- Offering amount
- $8M
- Amount sold
- $8M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$750KraisedMay 2019 · 9 investors · Other TechnologyRule 506(b)
▶$750KraisedMay 2019 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Sarah FayDirector
- Aaron MiramontesExecutive Officer
- Nicholas RiouxExecutive Officer, Director
- Siamak BaharlooExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $750K
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
IQVIA9 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Labcorp8 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
Science Exchange8 shared keywordsScience Exchange provides operational infrastructure for life sciences R&D, connecting organizations, suppliers, and workflows to streamline contracting, compliance, onboarding, and financial coordination across the research ecosystem.
Companies competing with Labviva for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Labviva do?
- Labviva is an AI-native procurement platform that unifies the life sciences supply chain, helping research organizations optimize procurement processes and reduce costs. The platform serves life sciences companies and research institutions by automating lab operations and inventory management.
- Who founded Labviva?
- Labviva was founded by Siamak, Siamak Baharloo in 2017.
- Who are Labviva's investors?
- Labviva's investors include BIOSPRING PARTNERS, Glasswing Ventures, Village Global, B Capital Group, B4 Capital, MassVentures, 53 Stations.
- How much funding has Labviva raised?
- Labviva has disclosed $33.8M raised across 3 rounds.
- Where is Labviva headquartered?
- Labviva is headquartered in Cambridge, US.